These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9203229)

  • 1. A meta-analysis of the effect of hormone replacement therapy upon depressed mood.
    Zweifel JE; O'Brien WH
    Psychoneuroendocrinology; 1997 Apr; 22(3):189-212. PubMed ID: 9203229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The other side of estrogen replacement therapy: outcome study results of mood improvement in estrogen users and nonusers.
    Miller KJ
    Curr Psychiatry Rep; 2003 Dec; 5(6):439-44. PubMed ID: 14609498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depressive symptoms, menopausal status, and climacteric symptoms in women at midlife.
    Bosworth HB; Bastian LA; Kuchibhatla MN; Steffens DC; McBride CM; Skinner CS; Rimer BK; Siegler IC
    Psychosom Med; 2001; 63(4):603-8. PubMed ID: 11485114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estradiol and the addition of progesterone increase the sensitivity to a neurosteroid in postmenopausal women.
    Wihlbäck AC; Nyberg S; Bäckström T; Bixo M; Sundström-Poromaa I
    Psychoneuroendocrinology; 2005 Jan; 30(1):38-50. PubMed ID: 15358441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EFFICACY OF ESTRADIOL IN PERIMENOPAUSAL DEPRESSION: SO MUCH PROMISE AND SO FEW ANSWERS.
    Rubinow DR; Johnson SL; Schmidt PJ; Girdler S; Gaynes B
    Depress Anxiety; 2015 Aug; 32(8):539-49. PubMed ID: 26130315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mood scores in relation to hormone replacement therapies during menopause: a prospective randomized trial.
    Onalan G; Onalan R; Selam B; Akar M; Gunenc Z; Topcuoglu A
    Tohoku J Exp Med; 2005 Nov; 207(3):223-31. PubMed ID: 16210834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual differences in changes in mood and platelet monoamine oxidase (MAO) activity during hormonal replacement therapy in menopausal women.
    Klaiber EL; Broverman DM; Vogel W; Peterson LG; Snyder MB
    Psychoneuroendocrinology; 1996 Oct; 21(7):575-92. PubMed ID: 9044441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine efficacy in menopausal women with and without estrogen replacement.
    Amsterdam J; Garcia-España F; Fawcett J; Quitkin F; Reimherr F; Rosenbaum J; Beasley C
    J Affect Disord; 1999 Sep; 55(1):11-7. PubMed ID: 10512601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy and menopause: a review of randomized, double-blind, placebo-controlled trials.
    Chang C; Lin CH
    Kaohsiung J Med Sci; 2003 Jun; 19(6):257-70. PubMed ID: 12873034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal and psychological treatment: therapeutic alternative for menopausal women?
    Anarte MT; Cuadros JL; Herrera J
    Maturitas; 1998 Jun; 29(3):203-13. PubMed ID: 9699191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menopausal depression: comparison of hormone replacement therapy and hormone replacement therapy plus fluoxetine.
    Liu P; He FF; Bai WP; Yu Q; Shi W; Wu YY; He DJ; Xiao JH; Zheng Y; Liao QP
    Chin Med J (Engl); 2004 Feb; 117(2):189-94. PubMed ID: 14975200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy: I. A pharmacoeconomic appraisal of its therapeutic use in menopausal symptoms and urogenital estrogen deficiency.
    Whittington R; Faulds D
    Pharmacoeconomics; 1994 May; 5(5):419-45. PubMed ID: 10147233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychological effects of continuation versus discontinuation of hormone replacement therapy by estrogen implants: a placebo-controlled study.
    Pearce J; Hawton K; Blake F; Barlow D; Rees M; Fagg J; Keenan J
    J Psychosom Res; 1997 Feb; 42(2):177-86. PubMed ID: 9076645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy to maintain cognitive function in women with dementia.
    Hogervorst E; Yaffe K; Richards M; Huppert F
    Cochrane Database Syst Rev; 2002; (3):CD003799. PubMed ID: 12137718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the quality of life of women in the climacteric period].
    Skrzypulec V; Drosdzol A; Ferensowicz J
    Ginekol Pol; 2004 May; 75(5):373-81. PubMed ID: 15524411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oestradiol treatment helped a depressed postmenopausal woman to stop her psychotropic medication: a case report.
    Korhonen S; Saarijärvi S
    Acta Psychiatr Scand; 1996 Dec; 94(6):480-1. PubMed ID: 9021004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships of serum estradiol levels, menopausal duration, and mood during hormonal replacement therapy.
    Klaiber EL; Broverman DM; Vogel W; Peterson LG; Snyder MB
    Psychoneuroendocrinology; 1997 Oct; 22(7):549-58. PubMed ID: 9373888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When does estrogen replacement therapy improve sleep quality?
    Polo-Kantola P; Erkkola R; Helenius H; Irjala K; Polo O
    Am J Obstet Gynecol; 1998 May; 178(5):1002-9. PubMed ID: 9609575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis.
    Hogervorst E; Williams J; Budge M; Riedel W; Jolles J
    Neuroscience; 2000; 101(3):485-512. PubMed ID: 11113299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms.
    Soares CN; Poitras JR; Prouty J; Alexander AB; Shifren JL; Cohen LS
    J Clin Psychiatry; 2003 Apr; 64(4):473-9. PubMed ID: 12716252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.